The estimated Net Worth of Jonathan Kennedy is at least $11.2 Milion dollars as of 6 December 2019. Mr. Kennedy owns over 7,600 units of Natus Medical Inc stock worth over $4,892,615 and over the last 12 years he sold NTUS stock worth over $3,007,486. In addition, he makes $3,335,550 as President, Chief Executive Officer oraz Director at Natus Medical Inc.
Sign up
Mr. Kennedy NTUS stock SEC Form 4 insiders trading
Jonathan has made over 9 trades of the Natus Medical Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 7,600 units of NTUS stock worth $171,000 on 6 December 2019.
The largest trade he's ever made was selling 47,600 units of Natus Medical Inc stock on 29 August 2018 worth over $1,754,060. On average, Jonathan trades about 6,843 units every 52 days since 2013. As of 6 December 2019 he still owns at least 148,441 units of Natus Medical Inc stock.
You can see the complete history of Mr. Kennedy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jonathan Kennedy biography
Jonathan A. Kennedy was Chief Financial Officer, Senior Vice President of the Company. Mr. Kennedy was Senior Vice President and Chief Financial Officer of Intersil Corporation, a global semiconductor manufacturer, since 2009. Prior to that, he was Intersil’s Corporate Controller since 2005 and Director of Finance since 2004. Before joining Intersil, Mr. Kennedy held management roles in Finance and Information Technology with Alcon Inc. and Harris Corporation. He holds a Bachelor of Science degree in Business Administration and a Master of Science degree in Accounting from the University of Central Florida. Mr. Kennedy is also a Certified Public Accountant.
What is the salary of Jonathan Kennedy?
As the President, Chief Executive Officer oraz Director of Natus Medical Inc, the total compensation of Jonathan Kennedy at Natus Medical Inc is $3,335,550. There are no executives at Natus Medical Inc getting paid more.
How old is Jonathan Kennedy?
Jonathan Kennedy is 49, he's been the President, Chief Executive Officer oraz Director of Natus Medical Inc since 2018. There are 17 older and no younger executives at Natus Medical Inc. The oldest executive at Natus Medical Inc is Kenneth Ludlum, 66, who is the Independent Director.
What's Jonathan Kennedy's mailing address?
Jonathan's mailing address filed with the SEC is C/O NATUS MEDICAL INCORPORATED, 6701 KOLL CENTER PARKWAY, SUITE 120, PLEASANTON, CA, 94566.
Insiders trading at Natus Medical Inc
Over the last 5 years, insiders at Natus Medical Inc have traded over $3,793,396 worth of Natus Medical Inc stock. The most active insiders traders include Dong Chune Christopher Chung, Joshua Levine oraz Jonathan Kennedy. On average, Natus Medical Inc executives and independent directors trade stock every 70 days with the average trade being worth of $543,972. The most recent stock trade was executed by Dong Chune Christopher Chung on 9 December 2021, trading 11,787 units of NTUS stock currently worth $243,755.
What does Natus Medical Inc do?
Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
What does Natus Medical Inc's logo look like?
Complete history of Mr. Kennedy stock trades at Iradimed Corp i Natus Medical Inc
Natus Medical Inc executives and stock owners
Natus Medical Inc executives and other stock owners filed with the SEC include:
-
Jonathan Kennedy,
President, Chief Executive Officer, Director -
B. Drew Davies,
Chief Financial Officer, Executive Vice President -
Austin Noll,
Executive Vice President and Chief Commercial Officer -
D. Christopher Chung,
Vice President - Quality, Regulatory Affairs and Chief Medical Officer -
Benjamin Drew Davies,
Exec. VP & CFO -
Austin F. Noll III,
Exec. VP & Chief Commercial Officer -
Dr. D. Christopher Chung M.D.,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Dr. D. Christopher Chung,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Barbara Paul,
Independent Chairman of the Board -
Kenneth Ludlum,
Independent Director -
Lisa Heine,
Independent Director -
Joshua Levine,
Independent Director -
Thomas Joseph Sullivan,
Pres, CEO & Director -
Alice Schroeder,
Independent Director -
Thomas Sullivan,
Independent Director -
Ilan Daskal,
Independent Director -
William Hill,
General Counsel -
Sean Langan,
Vice President of Global Operations -
Lisa Paul,
Vice President and Chief People Officer -
Douglas Balog,
VP, Gen. Counsel & Sec. -
Lisa Paul,
Chief People Officer & VP -
Ivan Pandiyan,
VP of Global R&D -
Seán Langan,
VP Global Operations -
Eric Guerin,
Director -
Bryant M Moore,
Director